Anavex Life Sciences (AVXL) news

Alzheimer stocks rose in regular trading, with Eli Lilly up 4.3%, Anavex Life Sciences gaining 3.7% and Biogen rising 3.3%.

Alzheimer’s-related stocks saw gains in regular trading on October 15, 2026, with Eli Lilly rising 4.3%, Anavex Life Sciences up 3.7%, and Biogen increasing by 3.3%. The movement reflects investor interest in the sector, particularly in companies advancing therapies for neurodegenerative diseases.…

Alzheimer stocks fell in intraday trading, with Eli Lilly down 4.5%, BioMarin Pharmaceutical down 4.5% and Anavex Life Sciences falling 4.1%.

Alzheimer's-related stocks experienced a decline during intraday trading on October 8, 2026. Eli Lilly and BioMarin Pharmaceutical both fell by 4.5%, while Anavex Life Sciences dropped 4.1%. The downturn reflects broader market sentiment amid ongoing developments in the biotech and healthtech…

Anavex stockholders elect all of the company’s director nominees at 2026 annual meeting

PVG Asset Management: Glass Lewis recommends Avxl stockholders vote gold universal proxy card at Sept 24, 2026 meeting

PVG Asset Management Corp. has announced that proxy advisory firm Glass Lewis has recommended Anavex Life Sciences Corp. (NASDAQ: AVXL) stockholders vote the GOLD Universal Proxy Card at the company’s Annual Meeting of Stockholders on September 24, 2026. This recommendation follows a broader…

ISS recommends holders vote for Of Anavex’s director nominees

In a recent development, Institutional Shareholder Services (ISS) has advised shareholders of Anavex Life Sciences Corp. to support the company’s director nominees at the upcoming annual meeting. This recommendation aligns with ISS’s evaluation of the board’s structure and governance practices .…